The associated MRI to provide guidance also provide imaging that provides temperature map to confirm the therapeutic effect of the ablation treatment and allows real time adjustments of treatment parameters.
New York, NY -- (SBWIRE) -- 12/16/2016 -- Magnetic resonance-guided focused ultrasound is a non-invasive treatment that combines two tools, focused magnetic resonance imaging, and ultrasound. The beam of ultrasound focused on targeted sites and penetrates through the soft tissues and, using MRI for monitoring guidance. The ultrasound beam causes an increase in temperature at target tissue and resulting in necrosis of tissue, while the surrounding structure is not disturbed by the beam. The associated MRI to provide guidance also provide imaging that provides temperature map to confirm the therapeutic effect of the ablation treatment and allows real time adjustments of treatment parameters.
The increasing demand for minimally invasive methods will drive the market for MRI-Guided Focused Ultrasound Devices. The system has several advantages such as the possibility of retreatment, alternative therapy after radiotherapy and surgery over traditional therapy and increasing awareness about the treatment option in developed countries will fuel the market for MRI-Guided Focused Ultrasound Devices. MRI-Guided Focused Ultrasound system offers fast recovery time and also has low complication rate as compared to surgery.
The market for MRI-Guided Focused Ultrasound Devices is segmented as device type, application, end user and geography. The device type market is further segmented by two type such as focused ultrasound device and magnetic resonance imaging. These are the two different devices which are used together to and forms MRI-Guided Focused Ultrasound system. By Application the market of MRI-Guided Focused Ultrasound Devices is segmented as Cancer (Brain Tumor, Breast cancer, Prostate cancer, Bone metastases, liver cancer, kidney cancer and pancreatic cancer, etc.), uterine fibroids, Parkinson's disease, essential tremor, etc. The increasing prevalence of cancer globally will drive the market for MRI-Guided Focused Ultrasound Devices in the forecast period. MRI-Guided Focused Ultrasound system is incision-less, noninvasive method used to treat abnormal benign growths in a woman's uterus known as fibroid tumors or fibroids. Uterine fibroids are one of the most common disorders of the uterus and mainly seen in women. The patient with essential tremor and not responding for medication MRI-Guided Focused Ultrasound Surgery is the best option of treatment for them.
By End User, the MRI-Guided Focused ultrasound devices market is segmented in hospitals, ambulatory surgical centers, diagnostic centers and clinics. Hospitals segment hold the largest share in MRI-Guided Focused ultrasound devices Market due to the availability of facilities are good in hospitals. After hospitals, Ambulatory surgical centers governs the market growth of MRI-Guided Focused ultrasound devices.
Recent conferences and workshops and rise in the number of surgeries performed by focused ultrasound surgery demonstrate that the technology is viable and is likely to see substantial development in the near future. MRI-guided focused ultrasound surgery was also named by many published medical agencies as one of top twenty most important invention and would be most useful in near future.
Geographically North America hold largest market share in overall MRI-Guided Focused ultrasound devices market was owing to increasing demand for non-invasive method and high product approval in the region for treatment. The market of Europe for MRI-Guided Focused Ultrasound devices will grow in forecast period due to the availability of devices in the region and awareness about system among people. The market in Asia Pacific will be smaller than North America and Europe due to less new product penetration in the region. The Latin America and the Middle East & Africa will less contribute in growth of MRI-Guided Focused ultrasound devices market.
Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/12727
In July 2016, The U.S. Food and Drug Administration approved first MRI-guided focused ultrasound device ExAblate Neuro to treat essential tremor. According to the National Institute of Neurological Disorders and Stroke, several million Americans, usually those over age 40, are affected by the condition. ExAblate Neuro uses magnetic resonance images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors. InSightec Ltd is the company which developed the system. In 2012, United States F.D.A. approved the MRI-Guided Focused ultrasound devices to initiate phase one study.
Some of the major market players in MRI-Guided Focused Ultrasound Devices Market globally include Koninklijke Philips N.V., Toshiba Corporation, Siemens AG, Hitachi Ltd., Samsung Electronics Co., Ltd., FUJIFILM Holdings Corporation, Esaote S.p.A., Mindray Medical International Ltd., and Analogic Corporation.
To Pre Book Single User License @ http://www.persistencemarketresearch.com/checkout/12727